Before PSM | After PSM | |||||
---|---|---|---|---|---|---|
Variable | RLA (n = 101) | OA (n = 46) | P value | RLA (n = 46) | OA (n = 46) | P value |
Age (years) | 47.15 ± 12.96 | 45.17 ± 10.29 | 0.364 | 48.15 ± 12.68 | 45.17 ± 10.29 | 0.219 |
Male | 48 (47.52) | 28 (60.87) | 0.123 | 24 (52.17) | 28 (60.87) | 0.400 |
Body mass index (kg × m−2) | 21.98 ± 3.04 | 21.67 ± 2.73 | 0.550 | 21.62 ± 2.70 | 21.67 ± 2.73 | 0.934 |
Hypertension | 66 (65.35) | 32 (69.57) | 0.856 | 29 (63.04) | 32 (69.57) | 0.508 |
VMA (μmol/24 h) | 96.75 (14.20, 689.60) | 110.20 (14.55, 371.48) | 0.966 | 119.00 (43.53, 340.58) | 110.20 (14.55, 371.48) | 0.372 |
eGFR (ml/min/1.73 m2) | 101.1 (62.2, 145.1) | 102.8 (71.8, 140.2) | 0.768 | 96.7 (73.3, 132.7) | 102.8 (71.8, 140.2) | 0.705 |
Preoperative hemoglobin (g/L) | 131 (71, 164) | 127 (72, 161) | 0.851 | 122 (80, 149) | 127 (72, 161) | 0.291 |
Comorbidities [n (%)] | ||||||
Myocardial infarction | 3 (2.97) | 0 (0) | 0.552 | 3 (6.52) | 0 (0) | 0.242 |
Stroke | 4 (3.96) | 3 (6.52) | 0.678 | 2 (4.35) | 3 (6.52) | 0.646 |
Coronary heart disease | 9 (8.91) | 2 (4.35) | 0.330 | 4 (8.70) | 2 (4.35) | 0.398 |
Diabetes | 18 (17.82) | 10 (21.74) | 0.575 | 9 (19.57) | 10 (21.74) | 0.797 |
ASA score [n (%)] | ||||||
III/IV | 29 (28.71) | 10 (21.74) | 0.375 | 12 (26.09) | 10 (21.74) | 0.625 |
Tumor size (cm) (range) | 6.48 ± 1.83 (5.1–9.8) | 7.92 ± 1.98 (5.1–13.2) | < 0.001 | 7.76 ± 2.02 (5.1 9.4) | 7.92 ± 1.98 (5.1–13.2) | 0.704 |
Tumor laterality [n (%)] | ||||||
Bilateral | 4 (3.96) | 2 (4.35) | 0.856 | 2 (4.35) | 2 (4.35) | 0.975 |
Right | 57 (56.44) | 28 (60.87) | 29 (63.04) | 28 (60.87) | ||
Left | 40 (39.60) | 16 (34.78) | 15 (32.61) | 16 (34.78) |